Back
Janux Therapeutics Vs. Ingevity Industry Stock Comparison
Buy
57
JANX
Janux Therapeutics
Last Price:
44.98
Seasonality Move:
-2.68%
Sell
15
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Buy
57
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $45.02. The Score for JANX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- JANX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $45.02
The current trend is relatively stagnant and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 47.43 | Sell |
| Chaikin Money Flow: | 226601 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.71 - 49.01) | Sell |
| Bollinger Bands (100): | (40.18 - 47.72) | Buy |
NGVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 47.28 | Sell |
| Chaikin Money Flow: | 509201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 40.1) | Sell |
| Bollinger Bands (100): | (36.91 - 47.49) | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.41 | Sell |
| 20-day SMA: | 46.88 | Sell |
| 50-day SMA: | 43.8 | Buy |
| 200-day SMA: | 36.66 | Buy |
| 8-day EMA: | 45.41 | Sell |
| 20-day EMA: | 45.96 | Sell |
| 50-day EMA: | 44.97 | Buy |
| 200-day EMA: | 37.31 | Buy |
NGVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.05 | Sell |
| 20-day SMA: | 37.78 | Sell |
| 50-day SMA: | 38.09 | Sell |
| 200-day SMA: | 44.29 | Sell |
| 8-day EMA: | 37.4 | Sell |
| 20-day EMA: | 37.93 | Sell |
| 50-day EMA: | 38.95 | Sell |
| 200-day EMA: | 43.92 | Sell |
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Janux Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ingevity Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||